All Stories

  1. The impact of influenza infection on young children, their family and the health care system

    Article • Influenza and Other Respiratory Viruses, September 2018, Wiley

    Professor Peter C Richmond

  2. Exposure to chorioamnionitis alters the monocyte transcriptional response to the neonatal pathogen Staphylococcus epidermidis

    Article • Immunology and Cell Biology, April 2018, Wiley

    Professor Peter C Richmond

  3. Immunogenicity and safety of single-dose, 13-valent pneumococcal conjugate vaccine in pediatric and adolescent oncology patients

    Article • Cancer, July 2017, Wiley

    Professor Peter C Richmond

  4. The impact of pandemic A(H1N1)pdm09 influenza and vaccine-associated adverse events on parental attitudes and influenza vaccine uptake in young children

    Article • Vaccine, July 2014, Elsevier

    Professor Peter C Richmond

  5. NOD1 and NOD2 expression and function in very preterm infant mononuclear cells

    Article • Acta Paediatrica, February 2014, Wiley

    Professor Peter C Richmond

  6. High Nasopharyngeal Carriage of Non-Vaccine Serotypes in Western Australian Aboriginal People Following 10 Years of Pneumococcal Conjugate Vaccination

    Article • PLoS ONE, December 2013, PLOS

    Professor Peter C Richmond

  7. Phagocytosis of neonatal pathogens by peripheral blood neutrophils and monocytes from newborn preterm and term infants

    Article • Pediatric Research, September 2013, Springer Science + Business Media

    Professor Peter C Richmond

  8. Changes in Patterns of Hospitalized Children With Varicella and of Associated Varicella Genotypes After Introduction of Varicella Vaccine in Australia

    Article • The Pediatric Infectious Disease Journal, May 2013, Wolters Kluwer Health

    Professor Peter C Richmond

  9. A Randomized, Controlled, Phase 1/2 Trial of a Neisseria meningitidis Serogroup B Bivalent rLP2086 Vaccine in Healthy Children and Adolescents

    Article • The Pediatric Infectious Disease Journal, April 2013, Wolters Kluwer Health

    Professor Peter C Richmond

  10. A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adults

    Article • Vaccine, March 2013, Elsevier

    Professor Peter C Richmond, Professor Michael Desmond Nissen

  11. Safety and Immunogenicity of Neonatal Pneumococcal Conjugate Vaccination in Papua New Guinean Children: A Randomised Controlled Trial

    Article • PLoS ONE, February 2013, PLOS

    Professor Peter C Richmond

  12. Neutrophil Extracellular Traps and Bacterial Biofilms in Middle Ear Effusion of Children with Recurrent Acute Otitis Media – A Potential Treatment Target

    Article • PLoS ONE, February 2013, PLOS

    Professor Peter C Richmond

  13. High pneumococcal serotype specific IgG, IgG1 and IgG2 levels in serum and the middle ear of children with recurrent acute otitis media receiving ventilation tubes

    Article • Vaccine, February 2013, Elsevier

    Professor Peter C Richmond

  14. Safety surveillance of influenza vaccine in pregnant women

    Article • Australian and New Zealand Journal of Obstetrics and Gynaecology, February 2013, Wiley

    Professor Peter C Richmond

  15. Does a 10-valent pneumococcal-Haemophilus influenzae protein D conjugate vaccine prevent respiratory exacerbations in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: protocol for a randomise...

    Article • Trials, January 2013, Springer Science + Business Media

    Professor Peter C Richmond

  16. A National Prospective Surveillance Study of Acute Rheumatic Fever in Australian Children

    Article • The Pediatric Infectious Disease Journal, January 2013, Wolters Kluwer Health

    Professor Peter C Richmond

  17. Inflammatory and Haematological Markers in the Maternal, Umbilical Cord and Infant Circulation in Histological Chorioamnionitis

    Article • PLoS ONE, December 2012, PLOS

    Professor Peter C Richmond

  18. New findings in the pathogenesis of otitis media

    Article • The Laryngoscope, December 2012, Wiley

    Professor Peter C Richmond

  19. Household transmission of respiratory viruses – assessment of viral, individual and household characteristics in a population study of healthy Australian adults

    Article • BMC Infectious Diseases, December 2012, Springer Science + Business Media

    Professor Peter C Richmond

  20. IgG Responses to Pneumococcal and Haemophilus Influenzae Protein Antigens Are Not Impaired in Children with a History of Recurrent Acute Otitis Media

    Article • PLoS ONE, November 2012, PLOS

    Professor Peter C Richmond

  21. Neonatal antigen-presenting cells are functionally more quiescent in children born under traditional compared with modern environmental conditions

    Article • Journal of Allergy and Clinical Immunology, November 2012, Elsevier

    Professor Peter C Richmond

  22. Nasopharyngeal carriage of Streptococcus pneumoniae: prevalence and risk factors in HIV-positive children in Tanzania

    Article • International Journal of Infectious Diseases, October 2012, Elsevier

    Professor Peter C Richmond

  23. Polymorphisms in key innate immune genes and their effects on measles vaccine responses and vaccine failure in children from Mozambique

    Article • Vaccine, September 2012, Elsevier

    Professor Peter C Richmond

  24. Can linked emergency department data help assess the out-of-hospital burden of acute lower respiratory infections? A population-based cohort study

    Article • BMC Public Health, August 2012, Springer Science + Business Media

    Professor Peter C Richmond

  25. Virus detection and its association with symptoms during influenza-like illness in a sample of healthy adults enrolled in a randomised controlled vaccine trial

    Article • Influenza and Other Respiratory Viruses, June 2012, Wiley

    Professor Peter C Richmond

  26. TLR3 and RIG-I gene variants: Associations with functional effects on receptor expression and responses to measles virus and vaccine in vaccinated infants

    Article • Human Immunology, June 2012, Elsevier

    Professor Peter C Richmond

  27. Impacts on influenza A(H1N1)pdm09 infection from cross-protection of seasonal trivalent influenza vaccines and A(H1N1)pdm09 vaccines: Systematic review and meta-analyses

    Article • Vaccine, May 2012, Elsevier

    Professor Peter C Richmond

  28. Children with otitis media mount a pneumococcal serotype specific serum IgG and IgA response comparable to healthy controls after pneumococcal conjugate vaccination

    Article • Vaccine, April 2012, Elsevier

    Professor Peter C Richmond

  29. Meningitis in children in Fiji: etiology, epidemiology, and neurological sequelae

    Article • International Journal of Infectious Diseases, April 2012, Elsevier

    Professor Peter C Richmond

  30. Responsiveness of human monocytes to the commensal bacterium Staphylococcus epidermidis develops late in gestation

    Article • Pediatric Research, March 2012, Springer Science + Business Media

    Professor Peter C Richmond

  31. Molecular Surveillance of True Nontypeable Haemophilus influenzae: An Evaluation of PCR Screening Assays

    Article • PLoS ONE, March 2012, PLOS

    Professor Peter C Richmond

  32. A genomics-based approach to assessment of vaccine safety and immunogenicity in children

    Article • Vaccine, February 2012, Elsevier

    Professor Peter C Richmond

  33. Development of Affordable Effective Vaccines against Whooping Cough for the Developing World

    Article • Journal of Vaccines & Vaccination, January 2012, OMICS Publishing Group

    Professor Peter C Richmond

  34. A Randomized Trial to Assess Safety and Immunogenicity of Alternative Formulations of a Quadrivalent Meningococcal (A, C, Y, and W-135) Tetanus Protein Conjugate Vaccine in Toddlers

    Article • The Pediatric Infectious Disease Journal, January 2012, Wolters Kluwer Health

    Professor Peter C Richmond

  35. Use of data linkage to investigate the aetiology of acute lower respiratory infection hospitalisations in children

    Article • Journal of Paediatrics and Child Health, November 2011, Wiley

    Professor Peter C Richmond

  36. Multi-species bacterial biofilm and intracellular infection in otitis media

    Article • BMC Pediatrics, October 2011, Springer Science + Business Media

    Professor Peter C Richmond

  37. Reactogenicity of two 2010 trivalent inactivated influenza vaccine formulations in adults

    Article • Vaccine, October 2011, Elsevier

    Professor Peter C Richmond

  38. Toll-like receptor 7 and 8 polymorphisms: associations with functional effects and cellular and antibody responses to measles virus and vaccine

    Article • Immunogenetics, September 2011, Springer Science + Business Media

    Professor Peter C Richmond

  39. Predominance of nontypeable Haemophilus influenzae in children with otitis media following introduction of a 3+0 pneumococcal conjugate vaccine schedule

    Article • Vaccine, July 2011, Elsevier

    Professor Peter C Richmond

  40. SLAM and DC-SIGN measles receptor polymorphisms and their impact on antibody and cytokine responses to measles vaccine

    Article • Vaccine, July 2011, Elsevier

    Professor Peter C Richmond

  41. Pneumococcal conjugate vaccination at birth in a high-risk setting: No evidence for neonatal T-cell tolerance

    Article • Vaccine, July 2011, Elsevier

    Professor Peter C Richmond

  42. Recurrence of extensive injection site reactions following DTPa or dTpa vaccine in children 4–6 years old

    Article • Vaccine, June 2011, Elsevier

    Professor Peter C Richmond

  43. IL-8 Polymorphisms Associated With Earlier And Increased Incidence Of Acute Lower Respiratory Infections In Children From Papua New Guinea (PNG)

    Article • May 2011, American Thoracic Society

    Professor Peter C Richmond

  44. Immunogenicity and Safety of an Investigational Combined Haemophilus influenzae Type B-Neisseria meningitidis Serogroups C and Y-Tetanus Toxoid Conjugate Vaccine

    Article • The Pediatric Infectious Disease Journal, March 2011, Wolters Kluwer Health

    Professor Peter C Richmond

  45. Vaccine Effectiveness Against Laboratory-confirmed Influenza in Healthy Young Children

    Article • The Pediatric Infectious Disease Journal, February 2011, Wolters Kluwer Health

    Professor Peter C Richmond, Professor Paul G Van Buynder

  46. A retrospective population-based cohort study identifying target areas for prevention of acute lower respiratory infections in children

    Article • BMC Public Health, December 2010, Springer Science + Business Media

    Professor Peter C Richmond

  47. Development of improved vaccines against whooping cough: Current status

    Article • Human Vaccines, July 2010, Taylor & Francis

    Professor Peter C Richmond

  48. Lessons from the first year of the WAIVE study investigating the protective effect of influenza vaccine against laboratory‐confirmed influenza in hospitalised children aged 6–59 months

    Article • Influenza and Other Respiratory Viruses, July 2010, Wiley

    Professor Peter C Richmond, Professor Paul G Van Buynder

  49. Innate immunity in human newborn infants: prematurity means more than immaturity

    Article • The Journal of Maternal-Fetal & Neonatal Medicine, June 2010, Taylor & Francis

    Professor Peter C Richmond

  50. The Changing Epidemiology of Invasive Pneumococcal Disease in Aboriginal and Non‐Aboriginal Western Australians from 1997 through 2007 and Emergence of Nonvaccine Serotypes

    Article • Clinical Infectious Diseases, June 2010, Oxford University Press (OUP)

    Professor Peter C Richmond

  51. Respiratory Viruses, Particularly Rhinoviruses, Are Commonly Detected In Papua New Guinean Children With Lower Respiratory Infection And When Healthy

    Article • May 2010, American Thoracic Society

    Professor Peter C Richmond

  52. TLR2 Mediates Recognition of Live Staphylococcus epidermidis and Clearance of Bacteremia

    Article • PLoS ONE, April 2010, PLOS

    Professor Peter C Richmond

  53. Th2-polarisation of cellular immune memory to neonatal pertussis vaccination

    Article • Vaccine, March 2010, Elsevier

    Professor Peter C Richmond

  54. Immunogenicity of a Monovalent 2009 Influenza A(H1N1) Vaccine in Infants and Children

    Article • JAMA, January 2010, American Medical Association (AMA)

    Professor Peter C Richmond

  55. Safety and immunogenicity of an inactivated thimerosal‐free influenza vaccine in infants and children

    Article • Influenza and Other Respiratory Viruses, October 2009, Wiley

    Professor Peter C Richmond

  56. Neonatal innate cytokine responses to BCG controlling T-cell development vary between populations

    Article • Journal of Allergy and Clinical Immunology, September 2009, Elsevier

    Professor Peter C Richmond

  57. Seasonality of Respiratory Viral Identification Varies With Age and Aboriginality in Metropolitan Western Australia

    Article • The Pediatric Infectious Disease Journal, July 2009, Wolters Kluwer Health

    Professor Peter C Richmond

  58. Neonatal pneumococcal conjugate vaccine immunization primes T cells for preferential Th2 cytokine expression: A randomized controlled trial in Papua New Guinea

    Article • Vaccine, February 2009, Elsevier

    Professor Peter C Richmond

  59. Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children

    Article • Vaccine, November 2008, Elsevier

    Professor Peter C Richmond

  60. Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults

    Article • Vaccine, August 2008, Elsevier

    Professor Peter C Richmond

  61. The role of chronic infection in children with otitis media with effusion: Evidence for intracellular persistence of bacteria

    Article • Otolaryngology, June 2008, Wiley

    Professor Peter C Richmond

  62. A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants

    Article • Vaccine, December 2007, Elsevier

    Professor Peter C Richmond

  63. DTPa‐HBV‐IPV vaccine for primary vaccination of infants

    Article • Journal of Paediatrics and Child Health, August 2007, Wiley

    Professor Peter C Richmond

  64. Neonatal immune responses to coagulase-negative staphylococci

    Article • Current Opinion in Infectious Diseases, August 2007, Wolters Kluwer Health

    Dr Ofer Levy, Professor Peter C Richmond

  65. Diverging trends for lower respiratory infections in non‐Aboriginal and Aboriginal children

    Article • Journal of Paediatrics and Child Health, May 2007, Wiley

    Professor Peter C Richmond

  66. Skin prick testing predicts peanut challenge outcome in previously allergic or sensitized children with low serum peanut‐specific IgE antibody concentration

    Article • Pediatric Allergy and Immunology, April 2007, Wiley

    Professor Peter C Richmond

  67. Infection Is the Major Component of the Disease Burden in Aboriginal and Non-Aboriginal Australian Children

    Article • The Pediatric Infectious Disease Journal, March 2007, Wolters Kluwer Health

    Professor Peter C Richmond

  68. Assessment of the potency and potential immunomodulatory effects of the measles mumps rubella and varicella vaccine in infants

    Article • Vaccine, February 2007, Elsevier

    Professor Peter C Richmond

  69. The effects of maternal smoking on early mucosal immunity and sensitization at 12 months of age

    Article • Pediatric Allergy and Immunology, January 2007, Wiley

    Professor Peter C Richmond

  70. The burden of rotavirus‐related illness among young children on the Australian health care system

    Article • Australian and New Zealand Journal of Public Health, October 2006, Elsevier

    Professor Peter C Richmond

  71. Toll-like receptor 2 ligands inhibit TH2 responses to mite allergen

    Article • Journal of Allergy and Clinical Immunology, May 2006, Elsevier

    Professor Peter C Richmond

  72. Immunogenicity and Boosting After a Reduced Number of Doses of a Pneumococcal Conjugate Vaccine in Infants and Toddlers

    Article • The Pediatric Infectious Disease Journal, April 2006, Wolters Kluwer Health

    Professor Peter C Richmond

  73. The burden of pneumonia in children: an Australian perspective

    Article • Paediatric Respiratory Reviews, June 2005, Elsevier

    Professor Peter C Richmond

  74. Vaccines for other neonatal infections: Pneumococcal disease: a major global health problem of young children

    Article • Expert Review of Vaccines, August 2004, Taylor & Francis

    Professor Peter C Richmond

  75. Hyperzincaemia and hypercalprotectinaemia: a new disorder of zinc metabolism

    Article • The Lancet, November 2002, Elsevier

    Professor Peter C Richmond, Beata Wolska-Kuśnierz

  76. Influence of Prior Meningococcal C Polysaccharide Vaccination on the Response and Generation of Memory after Meningococcal C Conjugate Vaccination in Young Children

    Article • The Journal of Infectious Diseases, August 2001, Oxford University Press (OUP)

    Professor Peter C Richmond

  77. Ability of 3 Different Meningococcal C Conjugate Vaccines to Induce Immunologic Memory after a Single Dose in UK Toddlers

    Article • The Journal of Infectious Diseases, January 2001, Oxford University Press (OUP)

    Professor Peter C Richmond

  78. Meningococcal serogroup C-specific IgG antibody responses and serum bactericidal titres in children following vaccination with a meningococcal A/C polysaccharide vaccine

    Article • FEMS Immunology & Medical Microbiology, May 2000, Oxford University Press (OUP)

    Professor Peter C Richmond

  79. Meningococcal C Polysaccharide Vaccine Induces Immunologic Hyporesponsiveness in Adults That Is Overcome by Meningococcal C Conjugate Vaccine

    Article • The Journal of Infectious Diseases, February 2000, Oxford University Press (OUP)

    Professor Peter C Richmond

  80. Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults

    Article • Vaccine, November 1999, Elsevier

    Professor Peter C Richmond

  81. Meningococcal Serogroup C Conjugate Vaccine Is Immunogenic in Infancy and Primes for Memory

    Article • The Journal of Infectious Diseases, June 1999, Oxford University Press (OUP)

    Professor Peter C Richmond

  82. Autism, inflammatory bowel disease, and MMR vaccine

    Article • The Lancet, May 1998, Elsevier

    Professor Peter C Richmond